Literature DB >> 2184923

Altered pharmacodynamics in the elderly.

J Feely1, D Coakley.   

Abstract

The importance of age-related changes in drug sensitivity is increasingly appreciated. More conclusive evidence is now being presented in combined kinetic and dynamic studies. The type, intensity, and duration of drug action may be affected, ranging from therapeutic failure to major drug toxicity. Alterations in physiologic and homeostatic systems, including the autonomic system, baroreceptors, thermoregulation, and balance, have been described. These may explain the propensity to postural hypotension, falls, hypothermia, and confusion, particularly following drug-induced decrements in these systems. Studies on the sensitivity to individual drugs produce a varied picture emphasizing the danger of generalizations. An increased sensitivity to many agents affecting the central nervous system, including benzodiazepines, halothane, metoclopramide, and narcotic analgesics, is becoming apparent. For the latter this may also be accompanied by an age-associated qualitative difference in toxicity. Whereas there is conclusive evidence of a reduced responsiveness to propranolol, the data are conflicting for calcium antagonists. The increased hypotensive response to ACE inhibitors is more likely due to kinetic factors. The anticoagulant response to warfarin is enhanced. Evidence is also emerging of a wide divergence in the sensitivity of different systems to the same drug--with aging the inotropic effect of theophylline is increased, but the bronchodilator response is decreased. It is becoming clear also that there is a need to separately study certain subgroups of the elderly population.

Entities:  

Mesh:

Year:  1990        PMID: 2184923

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  17 in total

Review 1.  Drug dosage in the elderly: dermatological drugs.

Authors:  Anna Flammiger; Howard Maibach
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

3.  Inappropriate drug prescriptions for elderly residents of board and care facilities.

Authors:  D L Spore; V Mor; P Larrat; C Hawes; J Hiris
Journal:  Am J Public Health       Date:  1997-03       Impact factor: 9.308

Review 4.  Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 5.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 6.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Drug therapy and the older person: role of the pharmacist.

Authors:  M J Denham; N L Barnett
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 8.  Management of older adults with hypercholesterolaemia.

Authors:  J T Pacala; P E McBride; S L Gray
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

Review 9.  Pharmacokinetic optimisation of drug therapy in elderly patients.

Authors:  B M Parker; B J Cusack; R E Vestal
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 10.  Delayed arousal.

Authors:  Zirka H Anastasian; Eugene Ornstein; Eric J Heyer
Journal:  Anesthesiol Clin       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.